Literature DB >> 23026499

Asthma symptom utility index: reliability, validity, responsiveness, and the minimal important difference in adult asthmatic patients.

Christian Bime1, Christine Y Wei, Janet T Holbrook, Marianna M Sockrider, Dennis A Revicki, Robert A Wise.   

Abstract

BACKGROUND: The evaluation of asthma symptoms is a core outcome measure in asthma clinical research. The Asthma Symptom Utility Index (ASUI) was developed to assess the frequency and severity of asthma symptoms. The psychometric properties of the ASUI are not well characterized, and a minimal important difference (MID) is not established.
OBJECTIVES: We assessed the reliability, validity, and responsiveness to change of the ASUI in a population of adult asthmatic patients. We also sought to determine the MID for the ASUI.
METHODS: Adult asthmatic patients (n = 1648) from 2 previously completed multicenter randomized trials were included. Demographic information, spirometric results, ASUI scores, and other asthma questionnaire scores were obtained at baseline and during follow-up visits. Participants also kept a daily asthma diary.
RESULTS: The internal consistency reliability of the ASUI was 0.74 (Cronbach α). Test-retest reliability was 0.76 (intraclass correlation). Construct validity was demonstrated by significant correlations between ASUI scores and Asthma Control Questionnaire scores (Spearman correlation r = -0.79; 95% CI, -0.85 to -0.75; P < .001) and Mini Asthma Quality of Life Questionnaire scores (r = 0.59; 95% CI, 0.51-0.61; P < .001). Responsiveness to change was demonstrated, with significant differences between mean changes in ASUI scores across groups of participants differing by 10% in percent predicted FEV(1) (P < .001) and by 0.5 points in Asthma Control Questionnaire scores (P < .001). Anchor-based and statistical methods support an MID for the ASUI of 0.09 points.
CONCLUSIONS: The ASUI is reliable, valid, and responsive to changes in asthma control over time. The MID of the ASUI (range of scores, 0-1) is 0.09.
Copyright © 2012 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23026499      PMCID: PMC3501248          DOI: 10.1016/j.jaci.2012.07.058

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  21 in total

1.  Quality criteria were proposed for measurement properties of health status questionnaires.

Authors:  Caroline B Terwee; Sandra D M Bot; Michael R de Boer; Daniëlle A W M van der Windt; Dirk L Knol; Joost Dekker; Lex M Bouter; Henrica C W de Vet
Journal:  J Clin Epidemiol       Date:  2006-08-24       Impact factor: 6.437

2.  Spirometric reference values from a sample of the general U.S. population.

Authors:  J L Hankinson; J R Odencrantz; K B Fedan
Journal:  Am J Respir Crit Care Med       Date:  1999-01       Impact factor: 21.405

3.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

4.  Severity assessment in asthma: An evolving concept.

Authors:  Mary K Miller; Charles Johnson; Dave P Miller; Yamo Deniz; Eugene R Bleecker; Sally E Wenzel
Journal:  J Allergy Clin Immunol       Date:  2005-10-03       Impact factor: 10.793

5.  Development and validation of the Mini Asthma Quality of Life Questionnaire.

Authors:  E F Juniper; G H Guyatt; F M Cox; P J Ferrie; D R King
Journal:  Eur Respir J       Date:  1999-07       Impact factor: 16.671

6.  Predicting episodes of poor asthma control in treated patients with asthma.

Authors:  Karen McCoy; David M Shade; Charles G Irvin; John G Mastronarde; Nicola A Hanania; Mario Castro; N R Anthonisen
Journal:  J Allergy Clin Immunol       Date:  2006-10-23       Impact factor: 10.793

7.  Integrating patient preferences into health outcomes assessment: the multiattribute Asthma Symptom Utility Index.

Authors:  D A Revicki; N K Leidy; F Brennan-Diemer; S Sorensen; A Togias
Journal:  Chest       Date:  1998-10       Impact factor: 9.410

8.  Development of the asthma control test: a survey for assessing asthma control.

Authors:  Robert A Nathan; Christine A Sorkness; Mark Kosinski; Michael Schatz; James T Li; Philip Marcus; John J Murray; Trudy B Pendergraft
Journal:  J Allergy Clin Immunol       Date:  2004-01       Impact factor: 10.793

9.  Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists.

Authors:  Michael Schatz; Christine A Sorkness; James T Li; Philip Marcus; John J Murray; Robert A Nathan; Mark Kosinski; Trudy B Pendergraft; Priti Jhingran
Journal:  J Allergy Clin Immunol       Date:  2006-03       Impact factor: 10.793

10.  Evaluating preference weights for the Asthma Symptom Utility Index (ASUI) across countries.

Authors:  Emuella M Flood; Erwin De Cock; Ann-Christin Mörk; Dennis A Revicki
Journal:  Health Qual Life Outcomes       Date:  2006-08-15       Impact factor: 3.186

View more
  16 in total

1.  Effect of Continuous Positive Airway Pressure on Airway Reactivity in Asthma. A Randomized, Sham-controlled Clinical Trial.

Authors:  Janet T Holbrook; Elizabeth A Sugar; Robert H Brown; Lea T Drye; Charles G Irvin; Alan R Schwartz; Robert S Tepper; Robert A Wise; Razan Z Yasin; Michael F Busk
Journal:  Ann Am Thorac Soc       Date:  2016-11

2.  Mometasone or Tiotropium in Mild Asthma with a Low Sputum Eosinophil Level.

Authors:  Stephen C Lazarus; Jerry A Krishnan; Tonya S King; Jason E Lang; Kathryn V Blake; Ronina Covar; Njira Lugogo; Sally Wenzel; Vernon M Chinchilli; David T Mauger; Anne-Marie Dyer; Homer A Boushey; John V Fahy; Prescott G Woodruff; Leonard B Bacharier; Michael D Cabana; Juan C Cardet; Mario Castro; James Chmiel; Loren Denlinger; Emily DiMango; Anne M Fitzpatrick; Deborah Gentile; Annette Hastie; Fernando Holguin; Elliot Israel; Daniel Jackson; Monica Kraft; Craig LaForce; Robert F Lemanske; Fernando D Martinez; Wendy Moore; Wayne J Morgan; James N Moy; Ross Myers; Stephen P Peters; Wanda Phipatanakul; Jacqueline A Pongracic; Loretta Que; Kristie Ross; Lewis Smith; Stanley J Szefler; Michael E Wechsler; Christine A Sorkness
Journal:  N Engl J Med       Date:  2019-05-19       Impact factor: 91.245

3.  Diagnostic accuracy of FEV1/forced vital capacity ratio z scores in asthmatic patients.

Authors:  Allison Lambert; M Bradley Drummond; Christine Wei; Charles Irvin; David Kaminsky; Meredith McCormack; Robert Wise
Journal:  J Allergy Clin Immunol       Date:  2015-04-09       Impact factor: 10.793

4.  Overweight children report qualitatively distinct asthma symptoms: analysis of validated symptom measures.

Authors:  Jason E Lang; Md Jobayer Hossain; John J Lima
Journal:  J Allergy Clin Immunol       Date:  2014-10-14       Impact factor: 10.793

5.  Advancing the symptom science model with environmental health.

Authors:  Jessica Castner; Azita Amiri; Jeannie Rodriguez; Luz Huntington-Moskos; Lisa M Thompson; Shuang Zhao; Barbara Polivka
Journal:  Public Health Nurs       Date:  2019-07-16       Impact factor: 1.462

6.  A new measure to assess asthma's effect on quality of life from the patient's perspective.

Authors:  Sandra R Wilson; Michael J Mulligan; Estela Ayala; Alan Chausow; Qiwen Huang; Sarah B Knowles; Santosh Gummidipundi; Mario Castro; Robert A Wise
Journal:  J Allergy Clin Immunol       Date:  2017-06-01       Impact factor: 10.793

7.  Effect of a soy isoflavone supplement on lung function and clinical outcomes in patients with poorly controlled asthma: a randomized clinical trial.

Authors:  Lewis J Smith; Ravi Kalhan; Robert A Wise; Elizabeth A Sugar; John J Lima; Charles G Irvin; Allen J Dozor; Janet T Holbrook
Journal:  JAMA       Date:  2015-05-26       Impact factor: 56.272

8.  Performance of the Asthma Impact on Quality of Life Scale (A-IQOLS) in diverse asthma research populations and demographic subgroups.

Authors:  Sandra R Wilson; Robert A Wise; Mario Castro; Michael J Mulligan; Estela Ayala; Alan Chausow; Qiwen Huang; Santosh Gummidipundi
Journal:  J Allergy Clin Immunol       Date:  2018-05-04       Impact factor: 10.793

9.  Effect of vitamin D3 on asthma treatment failures in adults with symptomatic asthma and lower vitamin D levels: the VIDA randomized clinical trial.

Authors:  Mario Castro; Tonya S King; Susan J Kunselman; Michael D Cabana; Loren Denlinger; Fernando Holguin; Shamsah D Kazani; Wendy C Moore; James Moy; Christine A Sorkness; Pedro Avila; Leonard B Bacharier; Eugene Bleecker; Homer A Boushey; James Chmiel; Anne M Fitzpatrick; Deborah Gentile; Mandeep Hundal; Elliot Israel; Monica Kraft; Jerry A Krishnan; Craig LaForce; Stephen C Lazarus; Robert Lemanske; Njira Lugogo; Richard J Martin; David T Mauger; Edward Naureckas; Stephen P Peters; Wanda Phipatanakul; Loretta G Que; Ajay Sheshadri; Lewis Smith; Julian Solway; Lisa Sullivan-Vedder; Kaharu Sumino; Michael E Wechsler; Sally Wenzel; Steven R White; E Rand Sutherland
Journal:  JAMA       Date:  2014-05       Impact factor: 56.272

10.  Sex differences in asthma symptom profiles and control in the American Lung Association Asthma Clinical Research Centers.

Authors:  Jennifer W McCallister; Janet T Holbrook; Christine Y Wei; Jonathan P Parsons; Cathy G Benninger; Anne E Dixon; Lynn B Gerald; John G Mastronarde
Journal:  Respir Med       Date:  2013-08-21       Impact factor: 3.415

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.